Claus Zachariae

Claus Zachariae serves as a Clinical Associate Professor within the Department of Dermatology and Venereology at the University of Copenhagen's Faculty of Health and Medical Sciences. His clinical practice is based at Gentofte Hospital (Gentofte Hospitalsvej 1, 2900 Hellerup) with academic affiliation to the Department of Clinical Medicine (Blegdamsvej 3, 2200 Copenhagen N). He maintains active clinical and research roles in dermatological disorders with particular focus on inflammatory skin conditions.

Dr. Zachariae's research spans multiple critical areas in dermatology including psoriasis therapeutics, genetic underpinnings of hidradenitis suppurativa, contact allergy mechanisms, and vaccine responses in immunocompromised skin disease patients. His work frequently examines adverse drug reactions to biologics, genetic associations in inflammatory skin disorders, and occupational exposure risks such as rubber accelerator sensitization. Current investigations leverage both clinical cohort studies and molecular techniques to address therapeutic challenges in immune-mediated dermatoses.

Analysis of his recent publications reveals strong emphasis on translational research connecting laboratory findings to clinical outcomes. Key trends include pharmacogenomic predictors of treatment response, long-term safety profiles of novel biologics, and molecular mechanisms of cross-reactivity in contact allergies. His collaborative network spans immunology, genetics, and occupational health disciplines with significant international partnerships.

Dr. Zachariae maintains active clinical supervision and research mentorship within the dermatology department, though specific trainee names aren't publicly enumerated. His work is supported through institutional hospital-academic partnerships and likely receives funding from Danish health research councils given the national scope of his psoriasis and contact dermatitis studies.

He leads investigations within specialized dermatology research units focusing on therapeutic safety and genetic dermatology, collaborating closely with immunology and pharmacology teams at Copenhagen University Hospital. Current laboratory work examines immune monitoring techniques and genetic profiling approaches for personalized dermatological care.